Yongpeng Sun-Tastaufen
BANNED
- Joined
- Oct 15, 2017
- Messages
- 28,401
- Reaction score
- -82
- Country
- Location
CanSinoBIO's inhalation COVID-19 shot in mid-stage trial, says CEO
An inhalation version of CanSino Biologics' (6185.HK), COVID-19 vaccine is being tested in a Phase II clinical trial, Chief Executive Yu Xuefeng said late on Wednesday.
BEIJING, June 2 (Reuters) - An inhalation version of CanSino Biologics' (6185.HK), COVID-19 vaccine is being tested in a Phase II clinical trial, Chief Executive Yu Xuefeng said late on Wednesday.
Yu made the comment at a panel of the Global Health Forum of the Boao Forum for Asia.
Reporting by Roxanne Liu and Ryan Woo Editing by David Goodman
Our Standards: The Thomson Reuters Trust Principles.
So it's like this yeah?
@nahtanbob @Hamartia Antidote @Oldman1 @denel @aziqbal @White and Green with M/S @rambro @FuturePAF @Han Patriot @Beast @Suika @vostok @mike2000 is back
Last edited:
